Shockwave Medical, Inc. which can be found using ticker (SWAV) now have 9 analysts in total covering the stock. The consensus rating is pointing to ‘buy’. The target price High/Low ranges between 325 and 165 calculating the mean target price we have $289.33. Given that the stocks previous close was at $282.65 and the analysts are correct then we can expect a percentage increase in value of 2.4%. Also worth taking note is the 50 day moving average now sits at $253.30 and the 200 day moving average is $244.14. The company has a market cap of 10.05B. The current stock price for Targa Resources Corp. is currently 274.45 USD
The potential market cap would be $10,289,626,260 based on the market consensus.
The company is not paying dividends at this time.
Other points of data to note are a P/E ratio of 43.49, revenue per share of 15.43 and a 16.07% return on assets.
Shockwave Medical, Inc. is a medical device company. The Company is focused on development and commercialization of products intended to transform the way calcified cardiovascular disease is treated. It provides care for the treatment of calcified cardiovascular disease through its differentiated local delivery of sonic pressure waves, intravascular lithotripsy (IVL). Its Shockwave M5 IVL catheter and Shockwave M5+ IVL catheter are five-emitter catheters for use in its IVL System in medium-diameter vessels for the treatment of peripheral artery disease (PAD). Its Shockwave S4 IVL catheter is a four-emitter catheter for use in its IVL System in small-diameter vessels for the treatment of PAD. Its Shockwave L6 IVL catheter is a six-emitter catheter for use in its IVL System in large diameter vessels for the treatment of PAD. Its Shockwave C2 IVL catheter and Shockwave C2+ IVL catheter are two-emitter catheters for use in its IVL System for the treatment of coronary artery disease (CAD).
